Jundishapur J Nat Pharm Prod
Jundishapur J Nat Pharm Prod

article information

Jundishapur Journal of Natural Pharmaceutical Products: Vol.17, issue 2; e117597
published online: February 19, 2022
article type: Research Article
received: July 3, 2021
revised: December 26, 2021
accepted: December 28, 2021
DOI: https://doi.org/10.5812/jjnpp.117597
Crossmark

In Vitro Antimalarial Activity and Phytochemical Analysis of Aerial Parts of Artemisia fragrans Willd.

authors:

avatar Pegah Akbari ORCID 1 , avatar Solmaz Asnaashari 2 , avatar Yahya Rahimpour ORCID 3 , avatar Parina Asgharian ORCID 4 , 5 , *

Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran
Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
Department of Pharmacognosy, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran

how to cite: Akbari P, Asnaashari S, Rahimpour Y, Asgharian P. In Vitro Antimalarial Activity and Phytochemical Analysis of Aerial Parts of Artemisia fragrans Willd.. Jundishapur J Nat Pharm Prod. 2022;17(2):e117597. https://doi.org/10.5812/jjnpp.117597.

Abstract

Background:

Malaria is one of the most momentous transmittable diseases globally. Medicinal herbs like Artemisia species might be possible sources of new, effective, and cheap antiplasmodial products, making up the leading molecules to investigate new antimalarial drugs. The Artemisia genus, which belongs to the Asteraceae family, is a widely distributed medicinal plant in Iran.

Methods:

In this study, the antimalarial activities of essential oil, different extracts, and vacuum liquid chromatography (VLC) fractions of A. fragrans Willd. were examined by a cell-free β-hematin formation assay. The aerial parts of A. fragrans were extracted by a Soxhlet extractor, and essential oil was obtained by a Clevenger apparatus. Then, GC-MS analysis was used to identify volatile compounds of essential oil and the 100% VLC fraction of chloroform.

Results:

Among the extracts, chloroform extract illustrated considerable antimalarial activity compared to the control (P < 0.001), with the IC50 value of 1.22 ± 0.05 mg/mL. Among the fractions, 100% VLC fraction of chloroform extract illustrated potent antimalarial effects compared to the control (P < 0.001). The volatile oil demonstrated moderate antimalarial effects (P < 0.001) compared with the control. Besides, GC-MS determined that sesquiterpenes in the 100% ethyl acetate fraction of the chloroform extract and oxygenated monoterpenes in the essential oil might be responsible for the potent antimalarial activity of this plant.

Conclusions:

The 100% ethyl acetate fraction of chloroform extract along with the essential oil of A. fragrans indicated potent and moderate activity, possibly due to sesquiterpenes and oxygenated monoterpenes, respectively.

1. Background

Malaria is one of the most momentous transmittable illnesses globally. It is the primary controversial issue in areas where the risk of malaria is high. According to the WHO report, malaria caused 429,000 deaths in 2015, and new malaria cases are predicted at approximately 212 million. Malaria is identified mainly in African countries. From 2010 to 2015, malaria's frequency and mortality rates decreased in Iran (1). The control of malaria has been far-fetched regarding the resistance of mosquitoes to insecticides and antimalarial drugs. Plasmodium falciparum is a parasitic species that has developed resistance to almost all kinds of antimalarial drugs, and P. viva has been resistant to chloroquine derivatives (2-4). Other reasons for the difficulty controlling malaria are the high price of antimalarial drugs and logistical difficulties, particularly in poor areas where malaria is endemic (5).

During the last 30 years, products with natural sources have made up two-thirds of all drugs (6). Medicinal herbs such as Cinchona species, Artemisia annua, Simaroubaceae, and Meliaceae family are the possible sources of new, effective, and cheap antiplasmodial products, which can make up the leading molecules to investigate new antimalarial drugs (7-10). The genus Artemisia, known as "Dermane" in Persian and "wormwood" in English, is the most prominent member of the Asteraceae family, with more than 300 species of fragrant and medical plants being widely disturbed all over the world, particularly in Southwest Asia and Central Europe (11-13). Essential oils of some species are used in aromatherapy and medicine, and the leaves of some others are used for cooking (14). Approximately 34 species of the Artemisia genus are found in Iran, including A. melanolepis and A. kermanensis, which are endemic (15). Investigating the biological activities of the secondary metabolites of this genus indicated that they had some medicinal effects such as anticonvulsant (16), apoptosis (17), immunosuppressive (18), anthelmintic (19), antimalarial (20), anti-inflammatory (21), anti-HIV (22), antibacterial (23), and antifungal (24) activities. The phytochemical investigations of this genus growing in Iran demonstrated monoterpenes and sesquiterpenes, particularly sesquiterpene lactones, in volatile oils (25). The main secondary metabolites in this genus include acetylene, coumarin, flavonoids, and terpenes. Terpenes, particularly sesquiterpenes characterized by several Asteraceae species, especially the Artemisia genus, are highly diverse and abundant (26). Artemisia fragrans, known as "Dermane ye matter" in Persian, grows in Iran, Russia, and neighboring areas and is famed for its strong fragrans (11).

2. Objectives

The present study aimed to screen the antimalarial activity of the aerial parts of A. fragrans.

3. Methods

3.1. Chemicals

Chloroquine diphosphate, hematin porcine, sodium acetate, sodium dodecyl sulfate (SDS), magnesium sulfate, sodium chloride, sodium hydrogen phosphate, sodium hydroxide, potassium chloride, sodium bicarbonate, and glucose were obtained from Sigma-Aldrich (United Kingdom). Oleic acid was attained from Fluka (India), and all solvents used for extraction and fractionation were obtained from Scharlau.

3.2. Plant Material

The aerial parts of A. fragrans Willd. were collected from Mughan in East Azarbaijan province, Iran. A voucher specimen in this collection with TBZFPH 404 has been deposited in the Herbarium of Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.

3.3. Extraction

The aerial parts of A. fragrans were dried at room temperature and powdered by a grinder. Then, 200 g of the dried powder of A. fragrans was extracted sequentially with n-hexane, chloroform, and methanol (1 L each solvent) with the Soxhlet method (Brand, Wertheim, Germany) at room temperature for eight hours. Then, all the extracts were concentrated using a rotary evaporator at a maximum temperature of 45ºC and low pressure.

3.4. Potent Extract Fractionation

The fractionation of chloroform extract (2 g) was conducted via vacuum liquid chromatography (VLC) method over silica gel (20 g of each) with a mixture of solvents with increasing polarity: (1) ethyl acetate (EtOAc)/n-hexane (10:90); (2) EtOAc/n-hexane (20:80); (3) EtOAc/n-hexane (40:60); (4) EtOAc/n-hexane (60:40); (5) EtOAc/n-hexane (80:20); and (6) EtOAc/n-hexane (100:00). All fractions were dried using a rotary evaporator at an ambient temperature of 45ºC.

3.5. Essential Oil

For making essential oil (EO), 100 g of the air-dried aerial parts of A. fragrans was powdered and extracted by a Clevenger apparatus (Germany) at room temperature for three hours. After decanting, the colored oils were recovered in the yield of 0.45% (v/w), and the oil was stored at 18°C for further investigation.

3.6. GC-MS Analysis

The EO and 100% VLC fraction were determined by a Shimadzu (Corporation, Kyoto, Japan) GC-MS QP5050A apparatus using the DB-1 capillary column (60 m × 0.25 mm id, film thickness 0.25 μm). Helium was used as the carrier gas at a 1.3 mL/min flow rate. For the EO analysis, the oven temperature was kept at 50°C for three minutes, then increased at a speed of 3°C/min to 260°C, and kept stable for nine minutes. For analysis of the 100% VLC fraction, the oven temperature was maintained at 50°C for four minutes, then it raised at a rate of 5°C/min to 300°C, and kept steady for 24 min. In addition, the injector temperature and split ratios were 220ºC and 1: 33, respectively. The components of EO and a potent fraction (100% EtOAc) were identified by Kovats Index (KI), retention time (RT), and mass spectrum (MS).

3.7. In Vitro β-hematin Formation Assay

The antimalarial activities of the extracts and different fractions of potent extracts and EO of A. fragrans were evaluated by the modified method of Fitch et al. (27, 28). Incubation of various concentrations of aerial parts (0 - 2 mg/mL in 10% DMSO) was done with 300 μM of hematin, dissolved in 0.1 M NaOH, 10 mM oleic acid, and 1 M HCl. Chloroquine diphosphate was utilized as a positive control. The samples were kept in an incubator overnight at 37ºC with regular shaking. Afterward, the samples were centrifuged (14,000 x g, 10 min, 21°C), and the hemozoin pellet was washed continuously with 2.5% (w/v) SDS in phosphate-buffered saline by sonication (30 min at 21°C) until the supernatant was transparent. Then, the hemozoin pellet was washed with 0.1 M sodium bicarbonate (pH 9.0) until the supernatant was clear again (usually 3 - 5 washes). After the final wash, the supernatant was eliminated, and the pellets were dissolved in 1 mL of 0.1 M NaOH before determining the amount of hemozoin by evaluating absorbance at 400 nm in a 1 mL quartz Corbett (Beckmann DU640 spectrophotometer). The results were recorded as percentage inhibition (I%) of heme polymerization/crystallization compared to a positive control (chloroquine) using the following formula: I% = [(AB–AA)/AB] ×100, where AB is the absorbance of blank (DMSO), and AA is the absorbance of the test sample.

3.8. Statistical Analysis

Experiments were tested in Quadruple measurements and illustrated as the mean ± SD. Furthermore, Microsoft Excel 2012 and Graph Pad Prism 8.0.2 (Graph Pad Software Inc., San Diego, CA, USA) were used for analyzing data. The IC50 and IC90 values were calculated from nonlinear regression analysis. Significant differences were determined using a one-way ANOVA test.

4. Results

4.1. In Vitro β-hematin Formation Assay

The results of the in vitro β-hematin formation assay of three different extracts of A. fragrans, six VLC fractions of chloroform extract, and essential oil are displayed in Table 1 and Figure 1. The inhibition of β-hematin formation by each extract/fraction is shown as a percentage (I%) and standard deviation. Among the extracts, the chloroform extract illustrated a considerable inhibitory effect with an IC50 value of 1.22 ± 0.05 mg/mL compared to the control group (DMSO) (P < 0.001). Among the six VLC fractions with different polarities, the 100% EtOAc fraction demonstrated significant antimalarial activity with an IC50 value of 0.11 ± 0.018 mg/mL compared to the control group (P < 0.001).

Table 1.

The 50% and 90 Inhibitory Concentrations (mg/mL) of the Aerial Parts of Artemisia fragrans in β-hematin Formation Assay

Plant and Extracts/fractionsIC50 (mg/mL)IC90 (mg/mL)
Aerial parts
MeOH22.33 ± 7.8068.75 ± 5.09
n-Hexane2.75 ± 0.0079.93 ± 0.53
CHCl31.22 ± 0.055.59 ± 0.08
CHCl3 fractions
10% EtOAc/n-Hexane0.64 ± 0.032.24 ± 0.29
20% EtOAc/ n-Hexane5.42 ± 0.0635.56 ± 2.44
40% EtOAc/ n-Hexane2.79 ± 1.2814.20 ± 1.56
60% EtOAc/ n-Hexane--
80% EtOAc/ n-Hexane1.34 ± 0.155.09 ± 0.62
100% EtOAc0.11 ± 0.01852.77 ± 8.65
Essential oil2.21 ± 0.1842.17 ± 8.27
Chloroquine0.04 ± 0.0020.35 ± 0.006

Abbreviations: Methanol, MeOH; Chloroform, CHCl3; Ethyl acetate, EtOAc.

Comparison of IC50 and IC90 values (mg/mL) of active extracts and fractions of potent extracts of Artemisia fragrans and chloroquine solution in β-hematin formation assay.
Comparison of IC50 and IC90 values (mg/mL) of active extracts and fractions of potent extracts of Artemisia fragrans and chloroquine solution in β-hematin formation assay.
Figure 1.

Comparison of IC50 and IC90 values (mg/mL) of active extracts and fractions of potent extracts of Artemisia fragrans and chloroquine solution in β-hematin formation assay.

Then, GC-MS analysis was used to assess the volatile compounds of the potent fraction. According to Table 2, aromadendrene oxide I (34.69%), p-Octyloxynitrobenzene (8.65%), α-Santonin (7.53%), 7a-Isopropenyl-4,5-dimethyloctahydroindene-4-carboxylic acid (5.96%), and β-Methyl ether dihydroartemisinin (5.72%) were found in this fraction.

Table 2.

Chemical Compositions of 100% Vacuum Liquid Chromatography Fraction

No.NameFormulaMWArea (%)RT
1Ethyl propionateC5H10O21020.326.515
2Butyric acidC4H8O2882.208.926
32-butanone,4-hydroxyC7H14O21300.6417.713
42 H-Pyran-3-ol, 6-ethenyltetrahydro-2,2,6-trimethylC10H18O21700.5227.933
5p-Menthane-1,2,4-triolC10H20O31880.3130.195
62-Hexanone, 3-methyl-4-methyleneC8H14O1260.1931.459
7LoliolideC11H16O31960.1737.02
84,6,10,10-Tetramethyl-5-oxatricyclo[4.4.0.0(1,4)]dec-2-en-7-oC13H20O22080.1839.268
9EpiglobulolC20H36O23080.2440.633
10HexaethylbenzeneC18H302461.2743.718
11VerrucarolC15H20O42661.6045.954
12Carbon oxideC10H14O21660.2846.137
13p-OctyloxynitrobenzeneC14H21NO32518.6546.445
14α-SantoninC15H18O32467.5346.589
15Cyclopropanaphthalen-3-one, octahydro-2,4a, 8,8-tetramethyl-, oximeC15H25NO2352.1646.915
16β-methyl ether of 11-epi-dihydro artemisininC16H26O52985.7248.068
17Aromadendrenepoxide-IC15H24O22034.6948.843
187a-Isopropenyl-4,5-dimethyloctahydroindene-4-carboxylic acidC15H24O22365.9649.673
196-Nitrocyclododecane-1,3-dioneC12H19NO42411.2150.631
20Limonene dioxideC10H16O21680.9550.833
21Cyclooctenone, dimmerC16H24O22481.1751.05
22cis-Z- α-Bisabolene epoxideC15H24O2200.5751.309
23d-NerolidolC15H26O2220.1852.321
Total76.71
Non-terpenoids24.88
Terpenoids51.83
Monoterpene1.54
Sesquiterpene50.29

Abbreviations: MW, molecular weight; RT, retention time (min).

4.2. GC-MS Analysis of Essential Oil

The essential oil components are presented in Table 3, based on their wash on the DB-1 column. According to Table 3, a total of 32 volatile components were identified in the aerial part of A. fragrans, which contained 99.04% essential oils. It contained 1.96% non-terpenoids and 97.08% terpenoids. Among the terpenoids, monoterpenes and sesquiterpenes were specified as 96.41% and 1.06 of the compounds, respectively. The GC-MS analysis of the EO led to the identification and quantification of five main monoterpenes, including β-thujone (47.43%), eucalyptol (18.04%), α-thujone (7.89%), camphor (7.22%), and 4-Terpineol (3.84%). The β-thujone is the main component of the A. fragrans essential oil.

Table 3.

Chemical Compositions of Essential Oil from the Aerial Part of Artemisia fragrans

No.NameFormulaMWArea (%)Ki
1 α-ThujeneC10H161520.39923.03
α-TerpineneC10H161360.71009.26
3 o-CymeneC10H141340.551012.12
4 EucalyptolC10H18O15418.041022.30
5 delta 3-CareneC10H161361.21049.54
6 trans-SabinenehydrateC10H18O1540.311054.59
7 TerpinoleneC10H161360.241079.50
8 β-ThujoneC10H16O15247.431091.60
9 α-ThujoneC10H16O1527.891099.60
10 TerpineolC10H18O1541.061108.18
11 CamphorC10H16O1527.221122.41
12 Pinion-3-olC10H16O1521.681124.25
13 (S) -cis-VerbenolC10H16O1520.311129.06
14 PinocarvoneC10H14O1500.511139.19
15 α-TerpineolC10H18O1540.461148.07
16 BorneolC10H18O1540.311150.24
17 4-TerpineolC10H18O1543.841163.31
18 Amyl vinyl carbinolC8H16O1280.211165.37
19 MyrtenalC10H14O1500.671170.28
20 α-TerpineolC10H18O1540.451173.23
21 MyrtenolC10H16O1520.351179.76
22 trans-PiperitolC10H18O1540.621181.09
23 CaravanC10H14O1500.361215.76
24 PiperitoneC10H16O1520.251227.30
25 cis-SabinolC10H16O1521.311273.11
26 CarvacrolC10H14O1500.261277.90
27 α-Terpineol acetateC12H20O21960.291299.53
28 α-Terpinyl acetateC12H20O21960.281333.27
29 Methyl cis-cinnamateC10H10O21620.311350.88
30 cis-JasmoneC11H16O1640.481368.37
31 Germacrene DC15H242040.681478.62
32 SpathulenolC15H24O2200.381567.27
Total99.04
Non-terpenoids1.96
Terpenoids97.08
Monoterpene96.41
Sesquiterpene1.06

Abbreviations: MW, molecular weight; KI, Kovats Index.

5. Discussion

The Anopheles mosquitoes’ bite infects the human body with Plasmodium, an intracellular parasite, causing malaria (29). Hemoglobin of infected erythrocytes is degraded to amino acids by Plasmodium to use the catabolic products as the primary source of nutrition for their development and proliferation. Free heme is a toxic by-product released by the degradation of hemoglobin by protease enzymes. Hence, the parasite detoxifies free heme in different ways. The most common way of overcoming this problem is by converting large amounts of heme to hemozoin or water-insoluble malaria pigment through the bio-crystallization process.

Although there is a different spectrum of chemical drugs for the treatment of parasite infection, the side effects of chemical compounds persuade researchers to discover novel approaches and drugs originating from natural sources. Artemisinin and 4-aminoquinolines derivatives (quinine, mefloquine, and chloroquine) are natural antimalarial compounds inhibiting hemozoin formation (30, 31). In the present study, A. fragrans was selected to evaluate its antimalarial activity and identify chemical compounds responsible for inhibiting the conversion of heme to hemozoin. Although all of the extracts exhibited significant antimalarial activity compared to the control (P < 0.001), based on the IC50 results, the CHCl3 extract (with the minimum IC50) was selected for further evaluation. It is worth mentioning that the CHCl3 extract significantly inhibited heme conversion compared to n-Hexane and MeOH extracts (P < 0.001). The mentioned results guided us to study the fractions of CHCl3 extract using the VLC method. The 100% EtOAc fraction was considered the most active fraction among the fractions compared to the control (P < 0.001). The GC-MS analysis of the 100% EtOAc VLC fraction indicated that aromadendrene oxide I was the main compound in this fraction, followed by p-Octyloxynitrobenzene and α-Santonian. In the 100% VLC fraction, sesquiterpenes are probably responsible for antimalarial effects with an acceptable amount.

Several studies have demonstrated the antimalarial activity of different species of Artemisia. For example, from three different Artemisia species, including A. ciniformis, A. turanica, and A. biennials, the dichloromethane extract of A. ciniformis revealed the most potent antimalarial activity (32). Furthermore, in the same study, A. ciniformis contained many sesquiterpenes, while A. biennis and A. tyrannical contained a few sesquiterpenes. Therefore, the antimalarial effect of A. ciniformis might be attributed to sesquiterpenes (33). In another investigation, the in vivo antimalarial activity of extracts and fractions of A. diffuse was determined, showing that the inhibitory effect of Plasmodium was due to the presence of a sesquiterpene called Tehranolide (34). According to the mentioned studies, sesquiterpenes were responsible for antimalarial effects, in parallel with the results of our study. As mentioned, the high antimalarial activity of the 100% EtOAc fraction was due to sesquiterpenes. Besides, α-santonin and dihydroartemisinin were other ingredients in 100% VLC fraction with high percentages, and their anti-Plasmodium efficacy was evaluated in various investigations. Although the antimalarial activity of α-santonin has not been proven yet in vitro, one study evaluated the antiplasmodial effect of synthesized peroxide derivatives of α-santonin in vivo (35). Moreover, Suputtamongkol et al. set the activity of a derivative of dihydroartemisinin in vivo (beta-methyl ether of 11-epi-dihydroartemisinin or Artemether) (36). Also, the antimalarial activity of the essential oil was significantly (IC50 = 2.21 ± 0.18 mg/mL, P < 0.001) higher than that of the control.

According to the GC-MS analysis results, 32 volatile components corresponding to 99.04% of the total oil were identified, representing high amounts of terpenoids. Among the terpenoids, oxygenated monoterpenes, monoterpenes, sesquiterpenes, and oxygenated sesquiterpenes were the main compounds of volatile oil, in sequence. Here, among the oxygenated monoterpenoids, beta-thujone, eucalyptol, α-thujone, and camphor were specified with high amounts. Other studies into EO of A. fragrans collected from a region in Behshahr indicated that most compounds of EO were camphor (46%), eucalyptol (23.7%), and camphene (7.9%) (13). Another study into EO revealed that the main compounds of the volatile oil of this plant gathered from the surrounding areas of Tabriz were eucalyptol (52.1%) and alpha-thujone (34.8%) (37). Moreover, Delazar et al. reported the main compounds of this essential oil as follows: (1) camphor (54.92%); (2) eucalyptol (11.48%); (3) α-thujone (9.21%); and (4) β-thujone (4.83%). It is worth mentioning that although the main compounds of EO of A. fragrans collected from different regions of East Azerbaijan province [one from the Botanical Garden of Drug Applied Research Center of Tabriz (Delazar et al.,) and one we studied EO from Moghan] are the same in different years and seasons, their percentage in some ingredients are different. For clarification, although in the current research, β-thujone had a high percentage, in the study conducted by Delazar et al., camphor held the first rank in terms of high percentage. Interestingly, eucalyptol is a common compound in all A. fragrans species collected from different regions of Iran (11).

In all the mentioned EO studies, oxygenated monoterpenes played a vital role in demonstrating the antimalarial activity, which is consistent with the results of various published papers. Chabir et al., in their study into the essential oil of the leaves of Melaleuca armillaris, showed that the antimalarial activity of EO of this plant was attributed to oxygenated monoterpenes like eucalyptol (38). Other investigations on four Salvia species rejected that the antiplasmodial activity of their essential oils may be due to high levels of monoterpenoids such as α-pinene, eucalyptol, and p-cymene (39). Furthermore, Sedaghat et al. concluded that the presence of oxygenated monoterpenes such as eucalyptol in the essential oil of Eucalyptus camaldulensis leaves significantly inhibited the growth of Anopheles mosquito larvae (40). Therefore, the antimalarial effect of A. fragrans essential oil may also be owing to oxygenated monoterpenes like eucalyptol.

5.1. Conclusion

The present study inspected the antimalarial activity of different extracts and essential oil of the aerial parts of A. fragrans growing in Iran. Among the extracts, the chloroform extract showed significant antimalarial activity compared to the control, with the IC50 value of 1.22 ± 0.05 mg/mL. The essential oil showed moderate antimalarial effects compared with the control. Among the fractions, 100% VLC fraction of chloroform extract showed potent antimalarial effects compared to the control. The GC-MS study determined that the sesquiterpene in the 100% EtOAc fraction of the chloroform extract and oxygenated monoterpenes in the essential oil might be responsible for the potent antimalarial activity of this plant. The results of the phytochemical study of A. fragrans may prompt researchers to conduct future studies on this plant.

Acknowledgements

References

  • 1.

    World Health Organization. World Health Statistics 2016: Monitoring Health for the SDGs Sustainable Development Goals. Geneva, Switzerland: World Health Organization; 2016.

  • 2.

    Khodadadi M, Nateghpour M, Souri E, Farivar L, Motevalli Haghi A, Rahimi-Froushani A, et al. Evaluation of Effectiveness of Ethanolic Extract of Artemisia aucheri, Individually and in Combination with Chloroquine, on Chloroquine - Sensitive Strain of Plasmodium berghei in Sourian Mice. Iran J Public Health. 2013;42(8):883-8. [PubMed ID: 26056643]. [PubMed Central ID: PMC4441920].

  • 3.

    Mengiste B, Makonnen E, Urga K. Invivo Antimalarial Activity of Dodonaea Angustifolia Seed Extracts Against Plasmodium Berghei in Mice Model. Momona Ethiopian Journal of Science. 2012;4(1):47. https://doi.org/10.4314/mejs.v4i1.74056.

  • 4.

    Muluye AB, Melese E, Adinew GM. Antimalarial activity of 80 % methanolic extract of Brassica nigra (L.) Koch. (Brassicaceae) seeds against Plasmodium berghei infection in mice. BMC Complement Altern Med. 2015;15:367. [PubMed ID: 26471058]. [PubMed Central ID: PMC4608310]. https://doi.org/10.1186/s12906-015-0893-z.

  • 5.

    Langhorne J, Ndungu FM, Sponaas AM, Marsh K. Immunity to malaria: more questions than answers. Nat Immunol. 2008;9(7):725-32. [PubMed ID: 18563083]. https://doi.org/10.1038/ni.f.205.

  • 6.

    Newman DJ, Cragg GM. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod. 2012;75(3):311-35. [PubMed ID: 22316239]. [PubMed Central ID: PMC3721181]. https://doi.org/10.1021/np200906s.

  • 7.

    Schmidt TJ, Khalid SA, Romanha AJ, Alves TM, Biavatti MW, Brun R, et al. The potential of secondary metabolites from plants as drugs or leads against protozoan neglected diseases - part II. Curr Med Chem. 2012;19(14):2176-228. [PubMed ID: 22414104].

  • 8.

    Ogungbe IV, Setzer WN. The Potential of Secondary Metabolites from Plants as Drugs or Leads against Protozoan Neglected Diseases-Part III: In-Silico Molecular Docking Investigations. Molecules. 2016;21(10). [PubMed ID: 27775577]. [PubMed Central ID: PMC6274513]. https://doi.org/10.3390/molecules21101389.

  • 9.

    Amoa Onguene P, Ntie-Kang F, Lifongo LL, Ndom JC, Sippl W, Mbaze LM. The potential of anti-malarial compounds derived from African medicinal plants, part I: a pharmacological evaluation of alkaloids and terpenoids. Malar J. 2013;12:449. [PubMed ID: 24330395]. [PubMed Central ID: PMC3878730]. https://doi.org/10.1186/1475-2875-12-449.

  • 10.

    Pandey A, Tripathi S. Concept of standardization, extraction and pre phytochemical screening strategies for herbal drug. J pharmacogn phytochem. 2014;2(5):115-9.

  • 11.

    Delazar A, Naseri M, Nahar L, Moghadam SB, Esnaashari S, Nazemiyeh H, et al. GC-MS analysis and antioxidant activities of essential oils of two cultivated Artemisia species. Chem Nat Compd. 2007;43(1):112-4. https://doi.org/10.1007/s10600-007-0047-8.

  • 12.

    Mirjalili MH, Tabatabaei SMF, Hadian J, Ebrahimi S, Sonboli A. Phenological Variation of the Essential Oil ofArtemisia scopariaWaldst. et Kit from Iran. J Essent Oil Res. 2007;19(4):326-9. https://doi.org/10.1080/10412905.2007.9699294.

  • 13.

    Morteza-Semnani K, Akbarzadeh M, Moshiri K. Essential oil composition ofArtemisia fragrans Willd. from Iran. Flavour Fragr J. 2005;20(3):330-1. https://doi.org/10.1002/ffj.1431.

  • 14.

    Duke J. Duke’s Phytochemical and Ethnobotanical Databases. Maryland, USA: Beltsville Agricultural Research Centre; 2005.

  • 15.

    Rustaiyan A, Masoudi S. Chemical constituents and biological activities of Iranian Artemisia species. Phytochem Lett. 2011;4(4):440-7. https://doi.org/10.1016/j.phytol.2011.07.003.

  • 16.

    Nasiri-Boroujeni S, Rahimi-Madiseh M, Lorigooini Z, Piroti K, Rafieian-Koupaei M, Amini-Khoei H. NMDA Receptor Mediates the Anticonvulsant Effect of Hydroalcoholic Extract of Artemisia persica in PTZ-Induced Seizure in Mice. Evid Based Complement Alternat Med. 2021;2021:6422451. [PubMed ID: 34394390]. [PubMed Central ID: PMC8360731]. https://doi.org/10.1155/2021/6422451.

  • 17.

    Nazeri M, Mirzaie-Asl A, Saidijam M, Moradi M. Methanolic extract of Artemisia absinthium prompts apoptosis, enhancing expression of Bax/Bcl-2 ratio, cell cycle arrest, caspase-3 activation and mitochondrial membrane potential destruction in human colorectal cancer HCT-116 cells. Mol Biol Rep. 2020;47(11):8831-40. [PubMed ID: 33141288]. https://doi.org/10.1007/s11033-020-05933-2.

  • 18.

    Zimmermann-Klemd AM, Reinhardt JK, Morath A, Schamel WW, Steinberger P, Leitner J, et al. Immunosuppressive Activity of Artemisia argyi Extract and Isolated Compounds. Front Pharmacol. 2020;11:402. [PubMed ID: 32322200]. [PubMed Central ID: PMC7157444]. https://doi.org/10.3389/fphar.2020.00402.

  • 19.

    Mravcakova D, Komaromyova M, Babjak M, Urda Dolinska M, Konigova A, Petric D, et al. Anthelmintic Activity of Wormwood (Artemisia absinthium L.) and Mallow (Malva sylvestris L.) against Haemonchus contortus in Sheep. Animals (Basel). 2020;10(2). [PubMed ID: 32013192]. [PubMed Central ID: PMC7070545]. https://doi.org/10.3390/ani10020219.

  • 20.

    Yang J, He Y, Li Y, Zhang X, Wong YK, Shen S, et al. Advances in the research on the targets of anti-malaria actions of artemisinin. Pharmacol Ther. 2020;216:107697. [PubMed ID: 33035577]. [PubMed Central ID: PMC7537645]. https://doi.org/10.1016/j.pharmthera.2020.107697.

  • 21.

    Jin L, Zhou W, Li R, Jin M, Jin C, Sun J, et al. A new polyacetylene and other constituents with anti-inflammatory activity from Artemisia halodendron. Nat Prod Res. 2021;35(6):1010-3. [PubMed ID: 31135186]. https://doi.org/10.1080/14786419.2019.1610962.

  • 22.

    Apaza Ticona L, Bermejo P, Guerra JA, Abad MJ, Beltran M, Martin Lazaro R, et al. Ethanolic extract of Artemisia campestris subsp. glutinosa (Besser) Batt. inhibits HIV-1 replication in vitro through the activity of terpenes and flavonoids on viral entry and NF-kappaB pathway. J Ethnopharmacol. 2020;263:113163. [PubMed ID: 32758575]. [PubMed Central ID: PMC7397943]. https://doi.org/10.1016/j.jep.2020.113163.

  • 23.

    Sultan MH, Zuwaiel AA, Moni SS, Alshahrani S, Alqahtani SS, Madkhali O, et al. Bioactive Principles and Potentiality of Hot Methanolic Extract of the Leaves from Artemisia absinthium L "in vitro Cytotoxicity Against Human MCF-7 Breast Cancer Cells, Antibacterial Study and Wound Healing Activity". Curr Pharm Biotechnol. 2020;21(15):1711-21. [PubMed ID: 32988347]. https://doi.org/10.2174/1389201021666200928150519.

  • 24.

    Feng X, Cao S, Qiu F, Zhang B. Traditional application and modern pharmacological research of Artemisia annua L. Pharmacol Ther. 2020;216:107650. [PubMed ID: 32758647]. https://doi.org/10.1016/j.pharmthera.2020.107650.

  • 25.

    Rustaiyan A, Ezzatzadeh E. Sesquiterpene Lactones and Pentamethoxylated Flavone from Artemisia kulbadica Boiss. & Buhse. Planta Med. 2011;77(12). https://doi.org/10.1055/s-0031-1282128.

  • 26.

    Ivanescu B, Miron A, Corciova A. Sesquiterpene Lactones from Artemisia Genus: Biological Activities and Methods of Analysis. J Anal Methods Chem. 2015;2015:247685. [PubMed ID: 26495156]. [PubMed Central ID: PMC4606394]. https://doi.org/10.1155/2015/247685.

  • 27.

    Fitch CD, Cai GZ, Chen YF, Shoemaker JD. Involvement of lipids in ferriprotoporphyrin IX polymerization in malaria. Biochim Biophys Acta. 1999;1454(1):31-7. [PubMed ID: 10354512]. https://doi.org/10.1016/s0925-4439(99)00017-4.

  • 28.

    Tripathi AK, Khan SI, Walker LA, Tekwani BL. Spectrophotometric determination of de novo hemozoin/beta-hematin formation in an in vitro assay. Anal Biochem. 2004;325(1):85-91. [PubMed ID: 14715288]. https://doi.org/10.1016/j.ab.2003.10.016.

  • 29.

    Malaguarnera L, Musumeci S. The immune response to Plasmodium falciparum malaria. Lancet Infect Dis. 2002;2(8):472-8. [PubMed ID: 12150846]. https://doi.org/10.1016/s1473-3099(02)00344-4.

  • 30.

    Asnaashari S, Heshmati Afshar F, Ebrahimi A, Bamdad Moghadam S, Delazar A. In vitro antimalarial activity of different extracts of Eremostachys macrophylla Montbr. & Auch. Bioimpacts. 2015;5(3):135-40. [PubMed ID: 26457251]. [PubMed Central ID: PMC4597161]. https://doi.org/10.15171/bi.2015.17.

  • 31.

    Bandyopadhyay U, Dey S. Antimalarial Drugs and Molecules Inhibiting Hemozoin Formation. In: Becker K, editor. Apicomplexan Parasites: Molecular Approaches toward Targeted Drug Development. New Jersey, USA: John Wiley & Sons; 2011. p. 205-34. https://doi.org/10.1002/9783527633883.ch11.

  • 32.

    Mojarrab M, Naderi R, Heshmati Afshar F. Screening of different extracts from artemisia species for their potential antimalarial activity. Iran J Pharm Res. 2015;14(2):603-8. [PubMed ID: 25901169]. [PubMed Central ID: PMC4403078].

  • 33.

    Iranshahi M, Emami SA, MAHMOUD SM. Detection of sesquiterpene lactones in ten Artemisia species population of Khorasan provinces. Iran J Basic Med Sci. 2007;10(3):183-8.

  • 34.

    Rustaiyan A, Nahrevanian H, Kazemi M. A new antimalarial agent; effect of extracts of Artemisia diffusa against Plasmodium berghei. Pharmacogn Mag. 2009;5(17):1-7.

  • 35.

    Tani S, Fukamiya N, Kiyokawa H, Musallam HA, Pick RO, Lee KH. Antimalarial agents. 1. alpha-Santonin-derived cyclic peroxide as potential antimalarial agent. J Med Chem. 1985;28(11):1743-4. [PubMed ID: 3906128]. https://doi.org/10.1021/jm00149a034.

  • 36.

    Suputtamongkol Y, Newton PN, Angus B, Teja-Isavadharm P, Keeratithakul D, Rasameesoraj M, et al. A comparison of oral artesunate and artemether antimalarial bioactivities in acute falciparum malaria. Br J Clin Pharmacol. 2001;52(6):655-61. [PubMed ID: 11736876]. [PubMed Central ID: PMC2014567]. https://doi.org/10.1046/j.1365-2125.2001.01458.x.

  • 37.

    Barazandeh MM. Essential Oil Composition ofArtemisia fragransWilld. from Iran. J Essent Oil Res. 2003;15(6):414-5. https://doi.org/10.1080/10412905.2003.9698626.

  • 38.

    Chabir N, Romdhane M, Valentin A, Moukarzel B, Marzoug HN, Brahim NB, et al. Chemical study and antimalarial, antioxidant, and anticancer activities of Melaleuca armillaris (Sol Ex Gateau) Sm essential oil. J Med Food. 2011;14(11):1383-8. [PubMed ID: 21476932]. https://doi.org/10.1089/jmf.2010.0168.

  • 39.

    Kamatou GP, van Zyl RL, van Vuuren SF, Viljoen AM, Figueiredo A, Barroso JG, et al. Chemical Composition, Leaf Trichome Types and Biological Activities of the Essential Oils of Four Related Salvia Species Indigenous to Southern Africa. J Essent Oil Res. 2019;18(sup1):72-9. https://doi.org/10.1080/10412905.2006.12067125.

  • 40.

    Sedaghat MM, Sanei Reza A, Mahnaz K, Abai MR, Hadjiakhoondi A, Mohtarami F, et al. Phytochemistry and larvicidal activity of Eucalyptus camaldulensis against malaria vector, Anopheles stephensi. Asian Pac J Trop Med. 2010;3(11):841-5. https://doi.org/10.1016/s1995-7645(10)60203-9.